ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

LIPO Lipella Pharmaceuticals Inc

0.703
-0.0098 (-1.37%)
Pre Market
Last Updated: 22:50:59
Delayed by 15 minutes

Period:

Draw Mode:

Volume 100
Bid Price 0.707
Ask Price 0.7128
News -
Day High

Low
0.64

52 Week Range

High
2.71

Day Low
Share Name Share Symbol Market Stock Type
Lipella Pharmaceuticals Inc LIPO NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.0098 -1.37% 0.703 22:50:59
Open Price Low Price High Price Close Price Previous Close
0.7128
Trades Shares Traded Average Volume 52 Week Range
1 100 - 0.64 - 2.71
Last Trade Type Quantity Price Currency
21:48:42 formt 100 US$ 0.703 USD

Lipella Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
4.44M 6.25M - 450k -4.62M -0.74 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Lipella Pharmaceuticals News

Date Time Source News Article
17/4/202422:00GlobeNewswire Inc.Lipella Pharmaceuticals Expands its Advisory Board to..
05/4/202423:00GlobeNewswire Inc.Lipella Pharmaceuticals to Publish Abstract Detailing..
03/4/202423:00GlobeNewswire Inc.Lipella Pharmaceuticals Announces FDA Type C Meeting for..
08/3/202407:23GlobeNewswire Inc.PRISM MarketView Spotlights Lipella Pharmaceuticals as it..
07/3/202409:05Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of..
07/3/202409:03Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of..
06/3/202400:00GlobeNewswire Inc.Lipella Pharmaceuticals Announces FDA Clearance of IND for..
28/2/202409:04Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]
28/2/202408:51Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K..
21/2/202400:00GlobeNewswire Inc.Lipella Pharmaceuticals to Present at PropThink Digital..
09/2/202416:15Edgar (US Regulatory)Form EFFECT - Notice of Effectiveness
08/2/202409:29Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial..

Historical LIPO Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.720.7350.700.71631512,302-0.017-2.36%
1 Month0.7410.7690.640.711706831,322-0.038-5.13%
3 Months0.97831.300.640.817681363,948-0.2753-28.14%
6 Months2.152.1510.640.93196342,703-1.45-67.30%
1 Year1.902.710.641.98217,768-1.20-63.00%
3 Years7.027.720.642.53342,862-6.32-89.99%
5 Years7.027.720.642.53342,862-6.32-89.99%

Your Recent History

Delayed Upgrade Clock